Sunedison Inc (NYSE:SUNE), Allied Nevada Gold Corp. (NYSEMKT:ANV) and InvenSense Inc (NYSE:INVN) hit midday in the green this Tuesday. Globalstar, Inc. (NYSEMKT:GSAT), Cal Dive International, Inc. (OTCMKTS:CDVI) and Amicus Therapeutics, Inc. (NASDAQ:FOLD), on the other hand, are in the red.
Sign Up For Our Free Newsletter
This Tiger Cub Giant Is Betting On Banks And Tech Stocks In The Recovery
The first two months of the third quarter were the best months for D1 Capital Partners' public portfolio since inception, that's according to a copy of the firm's August update, which ValueWalk has been able to review. Q2 2020 hedge fund letters, conferences and more According to the update, D1's public portfolio returned 20.1% gross Read More
SunEdison Surges
Sunedison Inc (NYSE:SUNE) surged +25.05% early in the day on the heels of news that it will acquire First Wind in a $2.4 billion deal. The solar energy company, a billionaire favorite, is in the portfolios of hedge fund magnates David Einhorn, Leon Cooperman and Dan Loeb, among others. It’s climbed +60.84% this year.
[drizzle]
Allied Nevada Gold Corp. (NYSEMKT:ANV) got a +10.78% boost today thanks to gold price increases. John Paulson has maintained a position in the gold and silver producer across several quarters, and George Soros initiated a position in the company in Q2.
Up +8.05% midday, InvenSense Inc (NYSE:INVN) has bounced a bit today, though it’s still down-25.89% for the year. The company, which is rumored to be a potential Qualcomm acquisition candidate, has been in Soros’ portfolio since the start of 2014.
Globalstar Tumbles Following CEO’s CNBC Stop
Globalstar, Inc. (NYSEMKT:GSAT) tumbled -8.57% today, just 24 hours after company CEO Jay Monroe paid a visit to CNBC to defend the stock. The George Soros pick has climbed +48% YTD.
Cal Dive International, Inc. (OTCMKTS:CDVI) dipped -5.69%, bringing its five-day loss to -35.56%. The marine contracting company has had a brutal 2014, its price falling -97.11% since the start of the year.
The share price of Amicus Therapeutics, Inc. (NASDAQ:FOLD) fell -5.67% today, coming back down a bit after yesterday’s surge. The stock has surged an impressive +171.06% YTD.
[/drizzle]